首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   20912篇
  免费   2159篇
  国内免费   983篇
耳鼻咽喉   113篇
儿科学   114篇
妇产科学   163篇
基础医学   2054篇
口腔科学   167篇
临床医学   3871篇
内科学   2945篇
皮肤病学   118篇
神经病学   824篇
特种医学   1039篇
外国民族医学   6篇
外科学   2490篇
综合类   2990篇
现状与发展   12篇
预防医学   921篇
眼科学   2648篇
药学   1516篇
  13篇
中国医学   608篇
肿瘤学   1442篇
  2024年   48篇
  2023年   659篇
  2022年   910篇
  2021年   1234篇
  2020年   1087篇
  2019年   616篇
  2018年   680篇
  2017年   464篇
  2016年   567篇
  2015年   876篇
  2014年   1790篇
  2013年   1473篇
  2012年   1868篇
  2011年   1874篇
  2010年   1439篇
  2009年   1241篇
  2008年   956篇
  2007年   1154篇
  2006年   841篇
  2005年   658篇
  2004年   591篇
  2003年   647篇
  2002年   489篇
  2001年   361篇
  2000年   299篇
  1999年   260篇
  1998年   210篇
  1997年   186篇
  1996年   79篇
  1995年   95篇
  1994年   69篇
  1993年   53篇
  1992年   81篇
  1991年   75篇
  1990年   58篇
  1989年   10篇
  1988年   31篇
  1987年   17篇
  1986年   1篇
  1985年   3篇
  1983年   2篇
  1982年   1篇
  1981年   1篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
目的构建在视网膜组织特异性表达的人血管内皮生长因子(VEGF)165基因。方法用聚合酶链反应(PCR)方法从BLAB/C鼠全基因组扩增能在视网膜组织特异性表达的rho启动子,经限制性内切酶纯化后克隆于质粒pcDNA3.1+-VEGF165中,建立重组质粒pcDNA3.1+-rho-VEGF165,通过限制性内切酶酶切分析及PCR鉴定筛选出正确重组质粒pcDNA3.1+-rho-VEGF165,由jetPEI介导转染人视网膜色素上皮细胞和人脐静脉内皮细胞,并通过免疫组织化学染色以及绘制细胞生长曲线检测在人视网膜色素上皮细胞和人脐静脉内皮细胞中VEGF蛋白的表达。结果在人视网膜色素上皮细胞中,重组质粒pcDNA3.1+-rho-VEGF165比质粒pcDNA3.1+-rho-VEGF165的VEGF蛋白表达强,在人脐静脉内皮细胞,两者的表达量无明显差别。结论pcDNA3.1+-rho-VEGF165载体的构建为进一步研究VEGF在视网膜新生血管形成中的致病机理提供基础材料,并为进一步建立视网膜特异性表达VEGF转基因鼠模型建立了基础。(中华眼底病杂志,2005,21:106-109)  相似文献   
92.
A new DRB1 allele, DRB1*0902, has been identified in an individual of the Jing ethnic minority. Its sequence was confirmed by sequencing of PCR products and clones. This allele differed by three nucleotides from DRB1*09012 at positions 157, 161 and 166, and resulted in amino acid motif substitution from VAES to DAEY.  相似文献   
93.
使用低流量循环密闭回路内注入给药法,比较1MAC代氟醚和安氟醚各14例维持全麻时循环动力苏醒情况和不良反应。结果;代氟醚在维持阶段对心血管系统的抑制较安氟醚为轻,很可能和代氟醚能使交感神经兴奋性增加有关。  相似文献   
94.
距骨的血液供应及其临床意义   总被引:30,自引:0,他引:30  
本文观察了24侧尸体足标本,均无已知临床血管疾病。在死后36~48小时之间行动脉灌注ABS填充剂,以化学腐蚀和手工剔除的方法清除软组织。距骨的血供来自小腿下部三根主要动脉的分支,即跗骨管动脉和三角支、近端和远端跗骨窦动脉、颈上支及后结节血管丛。跗骨管动脉常发自足底内侧动脉,而三角支多单独自胫后动脉发出;跗骨管动脉通常比三角支和跗骨窦动脉都来得细小。以上的这些动脉相互吻合,形成了一个骨膜血管网,覆盖于全部的距骨非关节面上。而且,环绕着跗骨管、跗骨窦、距骨颈的上面和距骨体部的内侧面,由三角支、跗骨管动脉、跗骨窦动脉、颈上支及其相互之间的吻合血管网形成了一个不定形的距骨动脉环。本文还讨论了距骨缺血性坏死与动脉环的可能关系,距骨骨折脱位或手术后的缺血性坏死是由于距骨动脉环的毁损或功能受影响所致。三角支在距骨骨折脱位时具有重要意义,手术或手法复位时应注意保护。  相似文献   
95.
目的探讨广泛性焦虑症(GAD)与抑郁症(MD)患者在免疫、内分泌和单胺递质方面的差异。方法 对30例GAD患者(焦虑症组)、38例MD患者(抑郁症组)在治疗(5-羟色胺再摄取抑制剂治疗6~8周)前后分别检测血清白细胞介素2(IL-2)、白细胞介素6(IL-6)、白细胞介素1β(IL-1β)、白细胞介素8(IL-8)、可溶性白细胞介素6受体(SIL-6R)、肿瘤坏死因子α(TNF-α)、皮质醇(CS)、促肾上腺皮质激素(ACTH)、肾上腺素(EPH)和去甲肾上腺素(NE)水平。选择30名年龄和性别与患者组相匹配的健康人为对照组。结果 (1)焦虑症组治疗前IL-8[(122±76)ng/L]、SIL-6R[(2 065±790)ng/L]水平均高于对照组(99±68)ng/L]、[(294±48)ng/L,IL-6水平为(1.6±0.7)ng/L,低于对照组[(5.3±2.7)ng/L],差异均有显著性意义(P<0.05);抑郁症组治疗前IL-2[(7.7±6.7)ng/L]、IL-8[(119±67)ng/L]、SIL-6R[(1308±371)ng/L]水平均高于对照组,差异均有显著性意义(均P<0.05)。经治疗后,焦虑症组IL-6[(4.3±1.2)ng/L]水平较治疗前升高,IL-8[(39±9)ng/L]水平较治疗前降低(P<0.05);抑郁症组IL-2[(2.4±1.2)ng/L]、IL-8[(47±15)ng/L]水平较治疗前降低(P<0.05);均接近于对照组水平(均P>0.05)。(2)焦虑症组治疗前ACIH[(49±28)ng/L]、EPH[(67±45)ng/  相似文献   
96.
97.
Objective: Based on the findings that erythropoietin (EPO) has been proved to be a multiple functional cytokine to attenuate ischemia–reperfusion (I/R) injury in various organs such as brain, heart, and kidney in animals, this experiment was designed to evaluate the effect of pretreatment with recombined human erythropoietin (rhEPO) on I/R-induced lung injury. Methods: Left lungs of rats underwent 90 min of ischemia and then were reperfused for up to 2 h. Animals were randomly divided into three experimental groups as sham group, I/R group, and rhEPO + I/R group (a single dose of rhEPO was injected intraperitoneally 3000 U/kg 24 h prior to operation). Lung injury was evaluated according to semi-quantitive analysis of microscopic changes, tissue polymorphonuclear neutrophils (PMNs) accumulation (myeloperoxidase (MPO) activity), and pulmonary microvascular permeability (Evan's blue dying method). Peripheral arterial and venous blood samples were obtained for blood–gas analysis after 5 min occlusion of right lung hilus at the end of reperfusion. The serum concentration of tumor necrosis factor (TNF)- was also measured by the method of enzyme-linked immunosorbent assay. Results: Histological injury scoring revealed significantly lessened lung alveolus edema and neutrophils infiltration in the rhEPO pretreated group compared with I/R group (p < 0.05). The rhEPO pretreated animals exhibited markedly decreased lung microvascular permeability (p < 0.05) and myeloperoxidase activity (p < 0.05). Blood–gas analysis demonstrated that the pretreated animals had significantly ameliorated pulmonary oxygenation function (p < 0.05). The serum concentration of tumor necrosis factor- in rhEPO pretreated group was markedly decreased compared with that of I/R group (p < 0.05). Conclusions: Pretreatment with rhEPO appears to attenuate I/R-induced lung injury. This function is partly related with the capacity that rhEPO inhibits the accumulation of polymorphonuclear neutrophils in lung tissue and decreases the systematic expression of tumor necrosis factor-.  相似文献   
98.
Z Wang 《中华外科杂志》1990,28(8):505-8, 512
A retrospective study of flow cytometric measurements on paraffin embedded tumor specimens from 188 patients with bladder tumor was made and the results were analyzed in combination with the morphological changes of bladder tumors. It was found that the DNA ploidy pattern, degree of infiltration and the multiplicity of bladder tumor were closely related with tumor recurrence, among which the DNA ploidy pattern was most significant. In the aneuploid bladder tumors the recurrent rate and mean annual recurrent frequency were 76.7% and 1.46, and those in the diploid bladder tumors were 18.7% and 0.33 respectively. Aneuploidy was the most indicative parameter in the recurrence of bladder tumor. In addition, according to the DNA ploidy pattern and DNA index, the aneuploid tumors in our group were divided into 4 types, namely, tetraploid tumors, non-euploid tumors with DNA index less than or equal to 1.5, non-euploid tumors with DNA index greater than 1.5 and two-aneuploid tumors. The results showed that the recurrent rate of tetraploid tumor was relatively low and it became higher and higher in the following order, e.g., non-euploid tumors with DNA index less than or equal to 1.5, non-euploid tumors with DNA index greater than 1.5 and two-aneuploid tumors, indicating that there were different biological behaviors in tumors with different ploidy patterns. Finally, the relationship between DNA ploidy pattern and tumor metastasis was also discussed.  相似文献   
99.
Y M Bao 《中华肿瘤杂志》1989,11(4):245-247
A comparative study of multiple modalities, radioimmunotherapy combined with cisplatin and MBV was made. The tumor size and macrophage activity (acid phosphatase) were measured after treatment. The results showed that the tumor inhibition rates were 48, 55, 74, 76, 79% in radioimmunotherapy, cisplatin, radioimmunotherapy + MBV, radioimmunotherapy + cisplatin and radioimmunotherapy + MBV + cisplatin groups, respectively. Radioimmunotherapy was effective in controlling tumor growth, especially in sequential treatment by two injections. Both cisplatin and MBV could increase therapeutic effect of radioimmunotherapy. Therefore, combination of the three modalities is the best choice for tumor growth control. The effectiveness of MBV may be related to the increase of macrophage activity. Preliminary clinical results were satisfactory. Decline in serum AFP level and shrinkage of tumor were observed in 80% (12/15) and 65% (13/20) of the patients. It is suggested that combination of multiple treatment modalities may provide an important approach to treat moderately advanced liver cancer.  相似文献   
100.
肝移植术后血管胆道并发症的介入治疗   总被引:2,自引:0,他引:2  
目的:评价介入治疗对肝移植后胆道、血管并发症的价值。材料和方法:18例肝移植患者接受了介入治疗。其中肝动脉狭窄8例,行肝动脉造影及溶栓治疗;下腔静脉及肝静脉狭窄2例,行内支架置入术;胆瘘及胆道狭窄8例,行PTCD治疗。结果:胆道并发症8例,PTCD治疗后症状消失;肝动脉狭窄8例,溶栓后肝动脉完全开放6例,1例血流部分开放,1例肝动脉血流未恢复再次肝移植治疗;下腔静脉及肝静脉狭窄2例内支架置入术后下腔静脉梗阻及肝肿大症状消失。结论:介入治疗是治疗肝移植后胆道血管并发症的有效方法。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号